Kaempferol suppresses androgen-dependent and androgen-independent prostate cancer by regulating Ki67 expression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kaempferol suppresses androgen-dependent and androgen-independent prostate cancer by regulating Ki67 expression
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-15
DOI
10.1007/s11033-022-07307-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen
- (2021) Xueni Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
- (2019) Peter Hammarsten et al. MODERN PATHOLOGY
- The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer
- (2019) Xueni Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
- (2019) Ronald de Wit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuating effect of kaempferol on neoplastic growth in different urological malignancies
- (2018) Shailendra Kapoor BIOMEDICINE & PHARMACOTHERAPY
- Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer
- (2018) Daniel E. Spratt INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
- (2018) João Lobo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models
- (2018) Kenza Mamouni et al. NEOPLASIA
- Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence
- (2018) Iain Miller et al. Cell Reports
- Zebrafish xenograft models of cancer and metastasis for drug discovery
- (2017) Hannah K Brown et al. Expert Opinion on Drug Discovery
- Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis
- (2017) Alejandro Berlin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Zebrafish Xenograft: An Evolutionary Experiment in Tumour Biology
- (2017) Rachael A. Wyatt et al. Genes
- KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
- (2016) William JF Green et al. BRITISH JOURNAL OF CANCER
- Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis
- (2014) Qiang Dang et al. MOLECULAR CARCINOGENESIS
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)
- (2014) LIAN TAO LI et al. Molecular Medicine Reports
- A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention
- (2012) Allen Y. Chen et al. FOOD CHEMISTRY
- Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells
- (2008) Sanghamitra Bandyopadhyay et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More